Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Georgian Med News ; (351): 146-151, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-39230237

RESUMEN

Physiological process of aging causes a slight deterioration in memorization, learning, and the speed of cognitive processes. There is often a big gap between established standards, norms that work for mass and individual cases, for which standards are no more than guidelines, not prescriptions and dementia could be caused by many factors, the most important of which are degenerative, vascular, and toxic. Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. Wilson's disease (WD) is an uncommon hereditary disorder caused by a deficiency in the ATP7B transporter. All of the above realized in the aim of our work: performing comprehensive clinical and laboratory examination of patients with multiple sclerosis and patients with Wilson's disease in order to study the problem of neurodegenerative diseases and their prevention. MATERIALS AND METHODS: The "Mini Mental Status Exam" scale was used for the screening assessment of the state of cognitive functions and the study of the level of intellectual productivity of patients. To determine the verbal memory, the method: "memorizing 10 words" was used, and the Derogatis SCl-90-P method was used to study the personality and emotional sphere. Psychodiagnostic examination was performed for 111 patients with MS and 33 patients with WD. RESULTS: Сognitive disorders were found in less than half of the patients (44.9%) in young patients with multiple sclerosis, whereas in the older age group, almost all patients (91.2%) had various cognitive disorders. Violation of verbal memory, of varying degrees of severity, was found in 69.1% of patients with multiple sclerosis. More than half of the patients with Wilson's disease (66.7%) had impaired productivity of cognitive functions of various degrees of severity. Identified violations were noted in 27.3% of patients (10 patients), among them 7 were aged 40 years or older and had not received pathogenetic treatment for a long time. Violations of mental functions of various nature and severity were found in 78.8% patients with Wilson's disease. They are characterized by dynamic and voluntary-regulatory thinking disorders, such as exhaustion of mental capacity (88.0%), a decrease in its speed characteristics (39.4%) and general productivity, as well as inertia (48.5%), impulsiveness (27.3%) of mental processes. Decrease in criticality of thinking was noted in 33.3% of patients. CONCLUSIONS: The structures that take participation in cognitive functions of the brain are always involved (sooner or later) in the pathogenetic process in patients with multiple sclerosis and hepatocerebral degeneration, that leads to the development of their defects. Therefore, for the treatment of these patients, a comprehensive, pathogenetically justified and personal fixed therapy is necessary. The development of palliative therapy, which will prevent the transformation of cognitive disorders into dementia, may become a prospect for further research.


Asunto(s)
Degeneración Hepatolenticular , Esclerosis Múltiple , Humanos , Esclerosis Múltiple/psicología , Esclerosis Múltiple/complicaciones , Adulto , Degeneración Hepatolenticular/psicología , Degeneración Hepatolenticular/fisiopatología , Degeneración Hepatolenticular/complicaciones , Femenino , Masculino , Persona de Mediana Edad , Cognición/fisiología , Adulto Joven , Trastornos del Conocimiento/etiología
2.
Georgian Med News ; (349): 110-115, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38963213

RESUMEN

The global medical problem has become the COVID-19 pandemic since 2019, which represents one of the most difficult medical realities. One of the crucial medical hypotheses is the effect of SARS-Cov-2 infection on mental health that requires creation of effective psychological and psychiatric management of such patients. In connection with described above, we set the task of our research to develop and test a complex of psychological interventions in the system of psychosocial rehabilitation of patients with cognitive disorders against the background of the endured SARS-Cov-2 infection. The material of the study was the data obtained after passing the GAD-7 test for level of anxiety detection. The persons were divided into two groups with patients who have a history of severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2) and non-suffered with coronavirus. At the end of the course of psychological rehabilitation, the GAD-7 test was repeated. It was established that people who have endured COVID-19 have a significantly higher level of anxiety during examining the initial level of anxiety by performing the GAD-7 test. So, if most of the examined had a minimal level of anxiety (68%) in the control group, then after COVID-19 the majority of patients had a moderate level of anxiety (64%), and 6% even had a high level of anxiety. A month after the initial testing, the group of patients (after COVID-19) who had not undergone psychological rehabilitation was still predominantly in the zone of moderate level of anxiety (54%). Going through psychological rehabilitation had positive consequences and the majority of patients moved into the minimal level of anxiety zone (58%). Majority of persons who endured COVID-19 suffer moderate level of anxiety with GAD-7 test 10.12±0.43 (6.92±0.33 for non-suffered). Psychological rehabilitation could reduce it to 7.24±0.36. The data obtained in the course of the work testify to the effectiveness of conducting a complex of psychotherapeutic interventions using cognitive training, cognitive-behavioral psychotherapy in the system of psychosocial rehabilitation of patients with cognitive disorders against the background of COVID-19 with reducing level of anxiety. Results provide critical information on the efficacy of psychological rehabilitation for persons who experience persistent cognitive deficits after COVID-19.


Asunto(s)
Ansiedad , COVID-19 , Humanos , COVID-19/psicología , COVID-19/rehabilitación , COVID-19/epidemiología , Ansiedad/psicología , Masculino , Femenino , Persona de Mediana Edad , Adulto , SARS-CoV-2 , Anciano
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA